Pelvic Cancer Registry for Online Adapted Radiotherapy

Launched by UNIVERSITY MEDICAL CENTER GOETTINGEN · Dec 14, 2023

Keywords

ClinConnect Summary

This clinical trial, called the Pelvic Cancer Registry for Online Adapted Radiotherapy, is studying how two different types of radiotherapy can help patients with pelvic or thoracic tumors. The trial focuses on comparing "online adapted radiotherapy" (oART) with "image-guided radiotherapy" (IGRT) to see if oART can reduce the side effects related to treatment by at least 10%. Additionally, it will look at how well each method controls tumors, any long-term side effects, and how patients feel about their quality of life during and after treatment.

To participate, patients must be at least 18 years old and have pelvic or thoracic tumors that require radiotherapy. However, those who have already received radiation treatment in the affected area cannot join. If eligible, participants will undergo radiotherapy and help researchers understand which method is more effective and safe. The trial is currently recruiting patients of all genders, and it's an important step in improving treatment options for those facing these types of cancer.

Gender

ALL

Eligibility criteria

• • INCLUSION CRITERIA
• • Patients with pelvic or thoracic tumors with an indication for radiotherapy
• • Patient information and declaration of consent
• • Patients age ≥ 18 years
• • EXCLUSION CRITERIA
• • Prior radiotherapy in affected site